We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.48B
AUM Growth
-$217M
Cap. Flow
-$417M
Cap. Flow %
-9.3%
Top 10 Hldgs %
80.33%
Holding
67
New
7
Increased
4
Reduced
20
Closed
7

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$104M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$29.3M
3
ROIV icon
Roivant Sciences
ROIV
+$21.8M
4
NMRA icon
Neumora Therapeutics
NMRA
+$21.2M
5
SGMT icon
Sagimet Biosciences
SGMT
+$19.3M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$113M
2
BEKE icon
KE Holdings
BEKE
+$81.9M
3
JD icon
JD.com
JD
+$76.4M
4
PDD icon
Pinduoduo
PDD
+$70.8M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$58.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.88%
2 Consumer Discretionary 31.35%
3 Technology 13.19%
4 Real Estate 10.63%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDOG icon
26
Datadog
DDOG
$94B
$19.9M 0.44%
218,100
– –
TMO icon
27
Thermo Fisher Scientific
TMO
$214B
$16.2M 0.36%
31,952
-9,500
-23% -$5.06M
NTES icon
28
NetEase
NTES
$83B
$15M 0.33%
149,700
– –
JD icon
29
JD.com
JD
$43.5B
$14.9M 0.33%
509,850
-2,194,350
-81% -$76.4M
AKRO
30
DELISTED
Akero Therapeutics
AKRO
$13.8M 0.31%
273,002
– –
EXAS
31
DELISTED
Exact Sciences
EXAS
$13.5M 0.3%
197,894
– –
SGMT icon
32
Sagimet Biosciences
SGMT
$435M
$12.8M 0.28%
+1,449,543
New +$19.3M
KNSA icon
33
Kiniksa Pharmaceuticals
KNSA
$6.23B
$12.1M 0.27%
698,741
– –
ONON icon
34
On Holding
ONON
$12.6B
$11.4M 0.26%
411,400
-1,705,024
-81% -$54M
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.9B
$10.1M 0.23%
114,042
-114,900
-50% -$10.2M
NBP
36
NovaBridge Biosciences American Depositary Shares
NBP
$186M
$9.12M 0.2%
6,909,220
– –
ARGX icon
37
argenx
ARGX
$55.2B
$8.24M 0.18%
16,765
-1,900
-10% -$929K
SE icon
38
Sea Limited
SE
$66.4B
$7.68M 0.17%
+174,800
New +$8.55M
PACB icon
39
Pacific Biosciences
PACB
$435M
$7.67M 0.17%
+918,892
New +$10.5M
TSLA icon
40
Tesla
TSLA
$1.18T
$7.51M 0.17%
+30,000
New +$7.71M
AXSM icon
41
Axsome Therapeutics
AXSM
$11.7B
$6.99M 0.16%
100,000
– –
SOHU
42
Sohu.com
SOHU
$352M
$6.89M 0.15%
731,800
– –
FUTU icon
43
Futu Holdings
FUTU
$14.3B
$4.62M 0.1%
80,000
-337,187
-81% -$18M
GOSS icon
44
Gossamer Bio
GOSS
$101M
$4.14M 0.09%
4,974,041
– –
ATAT icon
45
Atour Lifestyle Holdings
ATAT
$4.81B
$3.77M 0.08%
200,000
-461,522
-70% -$9.01M
VIPS icon
46
Vipshop
VIPS
$7.26B
$3.18M 0.07%
198,600
– –
EM
47
DELISTED
Smart Share Global Ltd
EM
$2.98M 0.07%
3,949,700
– –
TUYA
48
Tuya Inc
TUYA
$1.04B
$2.48M 0.06%
1,599,700
– –
BZ icon
49
Kanzhun
BZ
$7.19B
$1.88M 0.04%
123,700
+700
+0.6% +$11K
MOGU
50
MOGU Inc
MOGU
$16.4M
$1.78M 0.04%
847,510
– –
1
2
3

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, HHLR Advisors held 67 positions worth $4.48B, down 4.6% from $4.7B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

HHLR Advisors withdrew a net $417M in Q3 2023, closing 7 positions and reducing 20 holdings. Its most notable exit was Keurig Dr Pepper, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, HHLR Advisors opened a new position in RayzeBio, Inc. Common Stock worth $31M.

  • HHLR Advisors's largest Q3 2023 buy was RayzeBio, Inc. Common Stock: 1,395,716 shares worth $31M.
  • HHLR Advisors added most to Amazon in Q3 2023, an estimated $104M increase.
  • HHLR Advisors's biggest Q3 2023 reduction was Alibaba, cutting an estimated $113M.
  • HHLR Advisors fully exited Keurig Dr Pepper in Q3 2023, selling an estimated $17.7M.
  • HHLR Advisors's ten largest holdings make up 80% of its $4.48B portfolio in Q3 2023.
  • HHLR Advisors opened 7 new positions and closed 7 in Q3 2023.
  • HHLR Advisors's portfolio value fell 4.6% quarter-over-quarter to $4.48B.

Based on HHLR Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.